ZEUS System (Zio Watch) vs AVIEW
AI Verdict
Choose ZEUS System (Zio Watch) if…
Choose the ZEUS System (Zio Watch) if you require long-term, continuous cardiac monitoring for patients with suspected or known atrial fibrillation (AFib) or other cardiac arrhythmias. This wearable solution provides up to 14 days of ECG and PPG data collection, leveraging AI to deliver actionable insights into AFib burden and arrhythmia characteristics for physician review.
View ZEUS System (Zio Watch) →Choose AVIEW if…
Choose AVIEW if your practice needs an AI-powered platform to enhance the detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans. This comprehensive solution offers automated analysis of lung nodules, emphysema, and coronary artery calcium scoring, streamlining radiology workflows and providing detailed 3D visualizations and reports.
View AVIEW →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | ZEUS System (Zio Watch) | AVIEW |
|---|---|---|
| Pricing | Contact vendor | Subscription; one-off payment |
| Deployment | Cloud-based system with a wearable device | Cloud-based; Hybrid solution; Locally on dedicated hardware; Locally virtualized (virtual machine, Docker) |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ZEUS System (Zio Watch)Tool A (ZEUS System) offers a patient-centric approach with a wearable device and dedicated patient and provider apps, making continuous monitoring accessible and user-friendly for both parties. While Tool B (AVIEW) focuses on seamless integration into existing radiology workflows, Tool A's broader scope encompassing patient engagement through a dedicated app gives it a slight edge in overall usability.
Clinical Value
AVIEWTool B (AVIEW) provides a broader range of FDA-cleared diagnostic capabilities across multiple critical conditions, including lung cancer, COPD, and coronary artery calcification from CT scans, enhancing diagnostic precision. While Tool A (ZEUS System) is highly effective and FDA-cleared for cardiac arrhythmia detection, AVIEW's comprehensive multi-organ analysis from a single imaging modality offers a wider potential impact on patient care.
Pricing & Value
AVIEWTool B (AVIEW) offers greater transparency regarding its pricing models, specifying options like subscription or one-off payments based on installations or users. Tool A (ZEUS System) only states 'contact vendor' for pricing, making it difficult for potential buyers to assess the value proposition without direct engagement.
Enterprise Readiness
AVIEWTool B (AVIEW) demonstrates higher enterprise readiness through its flexible deployment options (cloud, hybrid, local, virtualized) and explicit integration capabilities with PACS/RIS/CIS. While Tool A (ZEUS System) is HIPAA compliant and cloud-based, and recently announced Epic integration, AVIEW's adaptability to diverse IT infrastructures and direct workflow integration offers a more robust solution for large healthcare systems.
Innovation
ZEUS System (Zio Watch)Tool A (ZEUS System) showcases significant innovation by combining an AI-powered wearable biosensor (Zio Watch) with AI for continuous, long-term cardiac monitoring, offering a novel and patient-centric approach to data collection and management. While Tool B (AVIEW) provides advanced AI for image analysis, Tool A's integration of a patient-worn device for proactive, extended monitoring represents a more disruptive innovation in healthcare delivery.
Support & Docs
ZEUS System (Zio Watch)Tool A (ZEUS System) provides comprehensive support, including 24/7 patient support via phone and email, detailed 'Instructions for Use' for both the device and software, and dedicated provider resources. In contrast, the available information for Tool B (AVIEW) primarily lists product catalogs and technical brochures, lacking explicit details on dedicated support channels or patient-facing FAQs.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | ZEUS System (Zio Watch) | AVIEW |
|---|---|---|
| Primary Focus | Long-term continuous cardiac monitoring for Atrial Fibrillation (AFib) and other cardiac arrhythmias. | Early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans. |
| Key Detection/Analysis Capabilities | Detects and characterizes Atrial Fibrillation (AFib) burden and other cardiac arrhythmias using AI-powered algorithms. | AI-powered lung nodule detection and characterization, emphysema quantification, and coronary artery calcium (CAC) scoring. |
| Data Acquisition Method | Wearable biosensor (Zio Watch) for continuous ECG and PPG data collection. | Analysis of CT scans. |
| Reporting & Workflow | Clinically actionable reports, ZioSuite portal, provider mobile app, and MyZio patient app for symptom logging and education. | 3D visualizations, comprehensive PDF reports, workflow automation, and integration with PACS/RIS/CIS. |
| Target Specialties | Cardiology, Family Medicine, Internal Medicine | Cardiology, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring ZEUS System (Zio Watch) and AVIEW.
Frequently Asked Questions
More Comparisons
More matchups featuring ZEUS System (Zio Watch) or AVIEW
Backers
Who funded each tool's parent company.